Toludesvenlafaxine hydrochloride

็›้…ธๆ‰˜้ฒๅœฐๆ–‡ๆ‹‰ๆณ•่พ›

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameToludesvenlafaxine hydrochloride
Drug Alias Name็›้…ธๅฎ‰่ˆ’ๆณ•่พ›Ansofaxine HydrochlorideODVP2 hydrochloride dihydrate็›้…ธๆ‰˜้ฒๅœฐๆ–‡ๆ‹‰ๆณ•่พ›็ผ“้‡Š็‰‡Ansofaxine hydrochloride dihydrate +[10]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders +[8]ย 
Global Approved IndicationsDepressive Disorder
Approved Indications in ChinaDepressive Disorder
Original Approved Country/TerritoryMainland China
Original Approved Date2022/11/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYantai UniversityLuye Pharma Group LtdShandong Luye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders +[4]ย 
Inactive IndicationsChronic PainDiabetic NeuropathiesFibromyalgia +[4]ย 

Other Information

ATC CodeN/A
Related LinksN/A